APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Peanut Allergy Therapeutics

Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.

Selected research

Market Outlook & Growth Opportunities

Global Peanut Allergy Therapeutics Market Outlook and Growth Opportunities 2026

Report ID 174022860428 December 2025204 pages

Choose your research edition.

Industry ResearchPeanut Allergy Therapeutics Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Peanut Allergy Therapeutics Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Peanut Allergy Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peanut Allergy Therapeutics Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Peanut Allergy Therapeutics Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.

United States is the largest consumption place, with a consumption market share nearly 45% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 31%.

Market competition is intense. Mylan, Bayer, UCB Pharma, J & J, Perrigo,top 5 players took 52% market share.

Read the full market overview

This report provides an overview of the global Peanut Allergy Therapeutics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peanut Allergy Therapeutics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peanut Allergy Therapeutics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Peanut Allergy Therapeutics market.

Peanut Allergy Therapeutics Segment by Company

Mylan

Bayer

UCB Pharma

J & J

Perrigo

GSK

Kaleo

Amneal Pharma

ALK Abello

Aimmune Therapeutics

HUAPONT Pharm

Allergy Therapeutics

ASIT Biotech

Sanofi

DBV Technologies

HAL Allergy

Intrommune Therapeutics

Peanut Allergy Therapeutics Segment by Type

Epinephrine Injection

Antihistamines

Oral Immunotherapy

Other

Peanut Allergy Therapeutics Segment by Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Other

Peanut Allergy Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Peanut Allergy Therapeutics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Peanut Allergy Therapeutics key companies, revenue, market share, and recent developments.

3. To split the Peanut Allergy Therapeutics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Peanut Allergy Therapeutics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Peanut Allergy Therapeutics significant trends, drivers, influence factors in global and regions.

6. To analyze Peanut Allergy Therapeutics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peanut Allergy Therapeutics industry.

Chapter 3: Detailed analysis of Peanut Allergy Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Peanut Allergy Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Peanut Allergy Therapeutics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Peanut Allergy Therapeutics Industry Trends Table 2. Peanut Allergy Therapeutics Industry Drivers Table 3. Peanut Allergy Therapeutics Industry Opportunities and Challenges Table 4. Peanut Allergy Therapeutics Industry Restraints Table 5. Global Peanut Allergy Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Peanut Allergy Therapeutics Revenue Share by Company (2021-2026) Table 7. Global Peanut Allergy Therapeutics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Peanut Allergy Therapeutics Key Company Manufacturing Base & Headquarters Table 9. Global Peanut Allergy Therapeutics Company, Product Type & Application Table 10. Global Peanut Allergy Therapeutics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Peanut Allergy Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Epinephrine Injection Table 15. Significant Companies of Antihistamines Table 16. Significant Companies of Oral Immunotherapy Table 17. Significant Companies of Other Table 18. Global Peanut Allergy Therapeutics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Peanut Allergy Therapeutics Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Peanut Allergy Therapeutics Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Peanut Allergy Therapeutics Sales Value Share by Type (2021-2026) Table 22. Global Peanut Allergy Therapeutics Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Pharmacy Table 24. Significant Companies of Retail Pharmacy Table 25. Significant Companies of Other Table 26. Global Peanut Allergy Therapeutics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Peanut Allergy Therapeutics Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Peanut Allergy Therapeutics Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Peanut Allergy Therapeutics Sales Value Share by Application (2021-2026) Table 30. Global Peanut Allergy Therapeutics Sales Value Share by Application (2027-2032) Table 31. Global Peanut Allergy Therapeutics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Peanut Allergy Therapeutics Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Peanut Allergy Therapeutics Sales Value Share by Region (2021-2026) Table 34. Global Peanut Allergy Therapeutics Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Peanut Allergy Therapeutics Sales Value Share by Region (2027-2032) Table 36. Global Peanut Allergy Therapeutics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Peanut Allergy Therapeutics Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Peanut Allergy Therapeutics Sales Value Market Share by Country (2021-2026) Table 39. Global Peanut Allergy Therapeutics Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Peanut Allergy Therapeutics Sales Value Market Share by Country (2027-2032) Table 41. Mylan Company Information Table 42. Mylan Business Overview Table 43. Mylan Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Mylan Peanut Allergy Therapeutics Product Portfolio Table 45. Mylan Recent Development Table 46. Bayer Company Information Table 47. Bayer Business Overview Table 48. Bayer Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Bayer Peanut Allergy Therapeutics Product Portfolio Table 50. Bayer Recent Development Table 51. UCB Pharma Company Information Table 52. UCB Pharma Business Overview Table 53. UCB Pharma Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. UCB Pharma Peanut Allergy Therapeutics Product Portfolio Table 55. UCB Pharma Recent Development Table 56. J & J Company Information Table 57. J & J Business Overview Table 58. J & J Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. J & J Peanut Allergy Therapeutics Product Portfolio Table 60. J & J Recent Development Table 61. Perrigo Company Information Table 62. Perrigo Business Overview Table 63. Perrigo Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Perrigo Peanut Allergy Therapeutics Product Portfolio Table 65. Perrigo Recent Development Table 66. GSK Company Information Table 67. GSK Business Overview Table 68. GSK Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. GSK Peanut Allergy Therapeutics Product Portfolio Table 70. GSK Recent Development Table 71. Kaleo Company Information Table 72. Kaleo Business Overview Table 73. Kaleo Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Kaleo Peanut Allergy Therapeutics Product Portfolio Table 75. Kaleo Recent Development Table 76. Amneal Pharma Company Information Table 77. Amneal Pharma Business Overview Table 78. Amneal Pharma Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Amneal Pharma Peanut Allergy Therapeutics Product Portfolio Table 80. Amneal Pharma Recent Development Table 81. ALK Abello Company Information Table 82. ALK Abello Business Overview Table 83. ALK Abello Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. ALK Abello Peanut Allergy Therapeutics Product Portfolio Table 85. ALK Abello Recent Development Table 86. Aimmune Therapeutics Company Information Table 87. Aimmune Therapeutics Business Overview Table 88. Aimmune Therapeutics Peanut Allergy Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio Table 90. Aimmune Therapeutics Recent Development Table 91. HUAPONT Pharm Company Information Table 92. HUAPONT Pharm Business Overview Table 93. HUAPONT Pharm Peanut Allergy Therapeutics Sales (M USD), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 94. HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio Table 95. HUAPONT Pharm Recent Development Table 96. Allergy Therapeutics Company Information Table 97. Allergy Therapeutics Business Overview Table 98. Allergy Therapeutics Peanut Allergy Therapeutics Sales (M USD), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 99. Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio Table 100. Allergy Therapeutics Recent Development Table 101. ASIT Biotech Company Information Table 102. ASIT Biotech Business Overview Table 103. ASIT Biotech Peanut Allergy Therapeutics Sales (M USD), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 104. ASIT Biotech Peanut Allergy Therapeutics Product Portfolio Table 105. ASIT Biotech Recent Development Table 106. Sanofi Company Information Table 107. Sanofi Business Overview Table 108. Sanofi Peanut Allergy Therapeutics Sales (M USD), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 109. Sanofi Peanut Allergy Therapeutics Product Portfolio Table 110. Sanofi Recent Development Table 111. DBV Technologies Company Information Table 112. DBV Technologies Business Overview Table 113. DBV Technologies Peanut Allergy Therapeutics Sales (M USD), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 114. DBV Technologies Peanut Allergy Therapeutics Product Portfolio Table 115. DBV Technologies Recent Development Table 116. HAL Allergy Company Information Table 117. HAL Allergy Business Overview Table 118. HAL Allergy Peanut Allergy Therapeutics Sales (M USD), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 119. HAL Allergy Peanut Allergy Therapeutics Product Portfolio Table 120. HAL Allergy Recent Development Table 121. Intrommune Therapeutics Company Information Table 122. Intrommune Therapeutics Business Overview Table 123. Intrommune Therapeutics Peanut Allergy Therapeutics Sales (M USD), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 124. Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio Table 125. Intrommune Therapeutics Recent Development Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Peanut Allergy Therapeutics Product Image Figure 2. Global Peanut Allergy Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peanut Allergy Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Peanut Allergy Therapeutics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Epinephrine Injection Image Figure 8. Antihistamines Image Figure 9. Oral Immunotherapy Image Figure 10. Other Image Figure 11. Global Peanut Allergy Therapeutics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Peanut Allergy Therapeutics Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Peanut Allergy Therapeutics Sales Value Share by Type (2021-2032) Figure 14. Hospital Pharmacy Image Figure 15. Retail Pharmacy Image Figure 16. Other Image Figure 17. Global Peanut Allergy Therapeutics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Peanut Allergy Therapeutics Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Peanut Allergy Therapeutics Sales Value Share by Application (2021-2032) Figure 20. Global Peanut Allergy Therapeutics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Peanut Allergy Therapeutics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Peanut Allergy Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 23. North America Peanut Allergy Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Peanut Allergy Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Peanut Allergy Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Peanut Allergy Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Peanut Allergy Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Peanut Allergy Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 29. South America Peanut Allergy Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Peanut Allergy Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Peanut Allergy Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Epinephrine Injection
  • Antihistamines
  • Oral Immunotherapy
  • Other
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • Other
Companies covered
  • Mylan
  • Bayer
  • UCB Pharma
  • J & J
  • Perrigo
  • GSK
  • Kaleo
  • Amneal Pharma
  • ALK Abello
  • Aimmune Therapeutics
  • HUAPONT Pharm
  • Allergy Therapeutics
  • ASIT Biotech
  • Sanofi
  • DBV Technologies
  • HAL Allergy
  • Intrommune Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Peanut Allergy Therapeutics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Peanut Allergy Therapeutics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Peanut Allergy Therapeutics Market Dynamics
  1. 2.1 Peanut Allergy Therapeutics Industry Trends
  2. 2.2 Peanut Allergy Therapeutics Industry Drivers
  3. 2.3 Peanut Allergy Therapeutics Industry Opportunities and Challenges
  4. 2.4 Peanut Allergy Therapeutics Industry Restraints
3 Peanut Allergy Therapeutics Market by Company
  1. 3.1 Global Peanut Allergy Therapeutics Company Revenue Ranking in 2025
  2. 3.2 Global Peanut Allergy Therapeutics Revenue by Company (2021-2026)
  3. 3.3 Global Peanut Allergy Therapeutics Company Ranking (2024-2026)
  4. 3.4 Global Peanut Allergy Therapeutics Company Manufacturing Base and Headquarters
  5. 3.5 Global Peanut Allergy Therapeutics Company Product Type and Application
  6. 3.6 Global Peanut Allergy Therapeutics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Peanut Allergy Therapeutics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Peanut Allergy Therapeutics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Peanut Allergy Therapeutics Market by Type
  1. 4.1 Peanut Allergy Therapeutics Type Introduction
  2. 4.1.1 Epinephrine Injection
  3. 4.1.2 Antihistamines
  4. 4.1.3 Oral Immunotherapy
  5. 4.1.4 Other
  6. 4.2 Global Peanut Allergy Therapeutics Sales Value by Type
  7. 4.2.1 Global Peanut Allergy Therapeutics Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Peanut Allergy Therapeutics Sales Value by Type (2021-2032)
  9. 4.2.3 Global Peanut Allergy Therapeutics Sales Value Share by Type (2021-2032)
5 Peanut Allergy Therapeutics Market by Application
  1. 5.1 Peanut Allergy Therapeutics Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Peanut Allergy Therapeutics Sales Value by Application
  6. 5.2.1 Global Peanut Allergy Therapeutics Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Peanut Allergy Therapeutics Sales Value by Application (2021-2032)
  8. 5.2.3 Global Peanut Allergy Therapeutics Sales Value Share by Application (2021-2032)
6 Peanut Allergy Therapeutics Regional Value Analysis
  1. 6.1 Global Peanut Allergy Therapeutics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Peanut Allergy Therapeutics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Peanut Allergy Therapeutics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Peanut Allergy Therapeutics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Peanut Allergy Therapeutics Sales Value (2021-2032)
  7. 6.3.2 North America Peanut Allergy Therapeutics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Peanut Allergy Therapeutics Sales Value (2021-2032)
  10. 6.4.2 Europe Peanut Allergy Therapeutics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Peanut Allergy Therapeutics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Peanut Allergy Therapeutics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Peanut Allergy Therapeutics Sales Value (2021-2032)
  16. 6.6.2 South America Peanut Allergy Therapeutics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Peanut Allergy Therapeutics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Peanut Allergy Therapeutics Sales Value Share by Country, 2025 VS 2032
7 Peanut Allergy Therapeutics Country-level Value Analysis
  1. 7.1 Global Peanut Allergy Therapeutics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Peanut Allergy Therapeutics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Peanut Allergy Therapeutics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Peanut Allergy Therapeutics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Peanut Allergy Therapeutics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Peanut Allergy Therapeutics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Peanut Allergy Therapeutics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mylan
  2. 8.1.1 Mylan Company Information
  3. 8.1.2 Mylan Business Overview
  4. 8.1.3 Mylan Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Mylan Peanut Allergy Therapeutics Product Portfolio
  6. 8.1.5 Mylan Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Peanut Allergy Therapeutics Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 UCB Pharma
  14. 8.3.1 UCB Pharma Company Information
  15. 8.3.2 UCB Pharma Business Overview
  16. 8.3.3 UCB Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 UCB Pharma Peanut Allergy Therapeutics Product Portfolio
  18. 8.3.5 UCB Pharma Recent Developments
  19. 8.4 J & J
  20. 8.4.1 J & J Company Information
  21. 8.4.2 J & J Business Overview
  22. 8.4.3 J & J Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 J & J Peanut Allergy Therapeutics Product Portfolio
  24. 8.4.5 J & J Recent Developments
  25. 8.5 Perrigo
  26. 8.5.1 Perrigo Company Information
  27. 8.5.2 Perrigo Business Overview
  28. 8.5.3 Perrigo Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Perrigo Peanut Allergy Therapeutics Product Portfolio
  30. 8.5.5 Perrigo Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GSK Peanut Allergy Therapeutics Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Kaleo
  38. 8.7.1 Kaleo Company Information
  39. 8.7.2 Kaleo Business Overview
  40. 8.7.3 Kaleo Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kaleo Peanut Allergy Therapeutics Product Portfolio
  42. 8.7.5 Kaleo Recent Developments
  43. 8.8 Amneal Pharma
  44. 8.8.1 Amneal Pharma Company Information
  45. 8.8.2 Amneal Pharma Business Overview
  46. 8.8.3 Amneal Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Amneal Pharma Peanut Allergy Therapeutics Product Portfolio
  48. 8.8.5 Amneal Pharma Recent Developments
  49. 8.9 ALK Abello
  50. 8.9.1 ALK Abello Company Information
  51. 8.9.2 ALK Abello Business Overview
  52. 8.9.3 ALK Abello Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ALK Abello Peanut Allergy Therapeutics Product Portfolio
  54. 8.9.5 ALK Abello Recent Developments
  55. 8.10 Aimmune Therapeutics
  56. 8.10.1 Aimmune Therapeutics Company Information
  57. 8.10.2 Aimmune Therapeutics Business Overview
  58. 8.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio
  60. 8.10.5 Aimmune Therapeutics Recent Developments
  61. 8.11 HUAPONT Pharm
  62. 8.11.1 HUAPONT Pharm Company Information
  63. 8.11.2 HUAPONT Pharm Business Overview
  64. 8.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio
  66. 8.11.5 HUAPONT Pharm Recent Developments
  67. 8.12 Allergy Therapeutics
  68. 8.12.1 Allergy Therapeutics Company Information
  69. 8.12.2 Allergy Therapeutics Business Overview
  70. 8.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio
  72. 8.12.5 Allergy Therapeutics Recent Developments
  73. 8.13 ASIT Biotech
  74. 8.13.1 ASIT Biotech Company Information
  75. 8.13.2 ASIT Biotech Business Overview
  76. 8.13.3 ASIT Biotech Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ASIT Biotech Peanut Allergy Therapeutics Product Portfolio
  78. 8.13.5 ASIT Biotech Recent Developments
  79. 8.14 Sanofi
  80. 8.14.1 Sanofi Company Information
  81. 8.14.2 Sanofi Business Overview
  82. 8.14.3 Sanofi Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sanofi Peanut Allergy Therapeutics Product Portfolio
  84. 8.14.5 Sanofi Recent Developments
  85. 8.15 DBV Technologies
  86. 8.15.1 DBV Technologies Company Information
  87. 8.15.2 DBV Technologies Business Overview
  88. 8.15.3 DBV Technologies Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  89. 8.15.4 DBV Technologies Peanut Allergy Therapeutics Product Portfolio
  90. 8.15.5 DBV Technologies Recent Developments
  91. 8.16 HAL Allergy
  92. 8.16.1 HAL Allergy Company Information
  93. 8.16.2 HAL Allergy Business Overview
  94. 8.16.3 HAL Allergy Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  95. 8.16.4 HAL Allergy Peanut Allergy Therapeutics Product Portfolio
  96. 8.16.5 HAL Allergy Recent Developments
  97. 8.17 Intrommune Therapeutics
  98. 8.17.1 Intrommune Therapeutics Company Information
  99. 8.17.2 Intrommune Therapeutics Business Overview
  100. 8.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio
  102. 8.17.5 Intrommune Therapeutics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst